Brief: Nona Biosciences Enters Into Antibody Discovery Agreement With Opko Health's Modex Therapeutics
23/05/2023 06:09
May 23 (Reuters) -
* NONA BIOSCIENCES ENTERS INTO ANTIBODY DISCOVERY AGREEMENT
WITH
OPKO HEALTH'S MODEX THERAPEUTICS
Source text for Eikon: ID:nPn9Zk4sJa
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study